Jas Uppal joined Gamida Cell as chief regulatory and quality officer in January 2020. She has over 25 years of experience in the biopharmaceutical industry, specializing in global drug development in oncology, neurology, immunology, endocrinology, and rare diseases. Jas has experience leading regulatory strategy, building centers of excellence, and driving operational excellence in the biotechnology industry. She brings to Gamida Cell strong scientific and regulatory knowledge, as well as extensive leadership in working with U.S., EU and international regulatory authorities.
Jas holds a Ph.D. in biochemistry from King’s College London.